New Congress Plans Immediate Vote on Embryonic Stem Cell Research
One of the first pieces of legislation to be considered by the newly-elected Congresswould mandate federal funding of embryonic stem cell research. On Thursday, January 11, the U.S. House of Representatives is expected to debate House Resolution 3 that will be similar or identical to a bill passed by the House and Senate last year. President Bush vetoed that bill and is expected to veto any new efforts to expand federal funding of unethical and unproven embryonic stem cell research. The House and the Senate would likely attempt to override a presidential veto.
Update - Embryonic Stem Cell Research Bill Passes U.S. House
On January 11, the United States House of Representatives passed legislation to federally fund embryonic stem cell research by a vote of 253-174. The White House immediately voiced opposition to the bill and President Bush has vowed to veto it should it reach his desk. Fortunately, the vote tally falls far short of the required two-thirds majority that would be required to override a presidential veto.
The legislation now moves to the Senate as S. 5 and is expected to receive a vote in the next few months. For more information on stem cell research, visit www.stemcellresearch.org or www.stemcellresearchfacts.com.